|

ACT001 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Nationwide Children's Hospital1

Indications

  • H3K27-altered High Grade Glioma1
  • Recurrent DIPG1
  • Refractory DIPG1
  • Progressive DIPG1
  • Diffuse Intrinsic Pontine Gliomas (DIPG)1

Aurora, Colorado1 trial

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Children's Hospital Colorado

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.